TCL Archive Pooled Analysis of Two LUX-Lung Trials Shows Prolonged Survival with Afatinib June 27, 2014
TCL Archive Five Year Survival Up To 48 Percent; DeVita Has “No Doubt” It Is Really Over 50 Percent Now December 2, 1983
TCL Archive ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small” July 30, 1976